BCLSI
IVVD icon

Bain Capital Life Sciences Investors’s Invivyd IVVD Stock Holding History

Bain Capital Life Sciences Investors’s Portfolio IVVD Stock Details IVVD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,799,595
Closed -$1.29M – 23
2025
Q2 		$1.29M Hold
1,799,595
– – 0.16% 21
2025
Q1 		$1.09M Hold
1,799,595
– – 0.16% 22
2024
Q4 		$797K Hold
1,799,595
– – 0.09% 25
2024
Q3 		$1.84M Hold
1,799,595
– – 0.19% 23
2024
Q2 		$1.98M Hold
1,799,595
– – 0.22% 23
2024
Q1 		$7.99M Sell
1,799,595
-137,612
-7% -$569K 0.64% 22
2023
Q4 		$7.63M Hold
1,937,207
– – 0.73% 20
2023
Q3 		$3.29M Hold
1,937,207
– – 0.37% 28
2023
Q2 		$2.03M Hold
1,937,207
– – 0.21% 31
2023
Q1 		$2.33M Hold
1,937,207
– – 0.29% 31
2022
Q4 		$2.91M Hold
1,937,207
– – 0.32% 30
2022
Q3 		$6.06M Hold
1,937,207
– – 0.72% 26
2022
Q2 		$6.35M Hold
1,937,207
– – 0.75% 25
2022
Q1 		$8.83M Hold
1,937,207
– – 0.86% 23
2021
Q4 		$14.1M Sell
1,937,207
-550,000
-22% -$14.3M 1.12% 20
2021
Q3 		$105M Buy
+2,487,207
New +$92.3M 6.52% 5

Other funds holding IVVD

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MIG
Mithril II GP Austin, Texas $64.5M AUM 360.75% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bain Capital Life Sciences Investors's IVVD Position: Q3 2025 in Review

Bain Capital Life Sciences Investors sold out of Invivyd (IVVD) in Q3 2025, closing a stake of 1,799,595 shares — an estimated $1.29M sold.

Bain Capital Life Sciences Investors first reported a position in IVVD in Q3 2021 and held it in 16 quarters. The position peaked at $105M in Q3 2021. 77 funds tracked by Wall St. Rank hold IVVD as of Q3 2025.

  • Bain Capital Life Sciences Investors reported no remaining Invivyd position as of Q3 2025 after selling out during the quarter.
  • Bain Capital Life Sciences Investors sold 1,799,595 Invivyd shares in Q3 2025, an estimated $1.29M.
  • Bain Capital Life Sciences Investors first reported a position in Invivyd in Q3 2021 and held it in 16 quarters.
  • Bain Capital Life Sciences Investors's Invivyd position peaked at $105M in Q3 2021.
  • 77 funds tracked by Wall St. Rank held Invivyd as of Q3 2025.

Based on Bain Capital Life Sciences Investors's 13F filing for Q3 2025, filed 14 Nov 2025.